Theseus Capital is a Principal Investor and Family Office Investment Vehicle focused on the Life Sciences and Technology Sectors. Theseus Capital’s Principal has over 20 years of experience investing in the capital markets. The Principal has built up considerable experience in finding early-stage Venture Capital opportunities. By working closely with leading scientists and entrepreneurs, Theseus Capital is assured of strong research underlying the ideas that drive its investments forward.
Theseus Capital was founded by Ron Bauer, a Venture Capital Investor with over 20 years of experience working closely with entrepreneurs and leading scientists.
Ron Bauer is a venture capitalist and serial entrepreneur with a particular interest in creative ways of financing businesses. He has been at the forefront of creative financing options for startups, early stage and mid stage businesses for over 20 years. His main focus is in the Life Sciences sector where he has created a number of exciting ventures side by side some of the world’s leading scientists as well as world class academic institutions that include Vanderbilt, Oxford, Cambridge, Stanford, Cornell, Hebrew University and Wash U to name a few.
Ron has a proven track record of nurturing innovative concepts and supporting dynamic entrepreneurs and scientists, taking them from early stage seed funding all the way through to public mergers, RTO’s or IPO’s or trade sales with larger companies, both public and private, across the globe. He is experienced in the M&A and Corporate Finance aspects of business and seasoned in the Capital Markets. He has experience listing portfolio companies on leading exchanges in the USA, Canada and the UK.
He was the Co-Founder and Director of Turkana Energy, which merged with Africa Oil (TSX: AOI) in July 2009. The company went on to have a peak market value of over $3 Billion CAD, having raised in excess of $1 Billion of equity after successfully drilling Turkana’s oil concession. The company is considered by many one of Canada’s most successful oil & gas exploration companies and discovered one of Africa’s largest oil sources this century.
He is the principal and founding investor in many biotech, tech and resources companies. Recently, he was a principal and founding investor in 180 Life Sciences (NASDAQ: ATNF), Hemogenyx Pharmaceuticals (LSE: HEMO) and Cognetivity Neurosciences (CSE: CGN).
Ron has a proven track record of raising capital across all sectors and all geographies in ever changing market conditions. By far his greatest personal quality is his ability to adapt himself to changing economic climates and diversifying sectors. He holds a Master of Business Administration degree from the University of Cambridge Judge Business School and is currently enrolled in a Doctorate of Business Administration program at Durham University.
Theseus Capital provides a wide range of value to the companies it invests in. Theseus Capital is actively involved in the whole life cycle of investment, from early-stage seed capital right up to the investment companies’ eventual exit.
With Theseus Capital, every type of transaction is possible and every type of financial instrument is available from equity to
debt. We offer a turn key solution which allows us to guide, mentor, and consult our portfolio companies.
Theseus Capital has close standing relationships with leading law, accounting, institutional brokerage and investment banking firms.
Theseus Capital has a solid set of criteria by which it selects the Life Sciences companies it invests in. The company looks for ventures led by:
Scientists from leading academic institutions
Individuals that have taken drugs to market or completed successful exits
People that have served in senior-level management in Biotech companies
Visionary entrepreneurs of all ages and experiences looking to change the world
ONE CAPITAL PLACE 3RD FLOOR
PO BOX 1564
CAYMAN ISLANDS KY1-1110